United States Over the Counter Drugs Market OCT2016 | Page 2
Global United States OTC Drugs Market
According to the report "United States Over The Counter Drugs Market", published by Market Data
Forecast, the global market is projected to reach USD 31.752 Billion by 2021, at a CAGR of 6.2% from
2016 to 2021.
For full report refer to http://www.marketdataforecast.com/market-reports/united-states-overthe-counter-drugs-market-805/
Over the counter (OTC) drugs are the drugs that can be bought without a doctor`s prescription from
pharmacies and local stores. In United States market OTC medicines provides 24/7 access of drugs to
healthcare options for busy families and caregivers. Approximately there are around 2.9 billion retail
trips annually to purchase OTC products. To obtain access these OTC drugs there are about 54,000
pharmacies, and more than 7,50,000 retail outlets in United States. On average, United States
households spend about $338 per year on Over the Counter Drugs.
Free sample for the report is available at http://www.marketdataforecast.com/marketreports/united-states-over-the-counter-drugs-market-805/request-sample
United States OTC drugs market is driven by factors such as active approach towards ailments and
cultural shift among people are the two major factors driving the market of United States OTC drugs
market. While drug abuse is the major factor hindering the market growth.
1) By Formulation Type
Tablets
Liquids
Ointments
Sprays
2) By Product Type
Cough, Cold and Flu Drugs
Analgesics
Dermatologics
Gastrointestinal Drugs
Antiseptics
Anti-Allergy Drugs
Smoking Cessation Aids
Ophthalmics
Vitamins and Minerals
Sleep Aids
Weight Loss/Diet Drugs
Others (Ear Drops & Diuretics)
3) By Distribution Channels
Pharmacies / Drug stores,
Supermarkets/Hypermarkets,
Convenience Stores and
Others.
Some of the major companies dominating the market are GlaxoSmithKline, Johnson and Johnson,
Novartis, Bayer, Pfizer, Boehringer Ingelheim, Sanofi, Takeda and PGT Healthcare
+1 888-702-9626 | www.marketdataforecast.com | [email protected]